Clinical trial
Exploration and Study on the Identification of Various Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
NCT06528418 is registered in ClinicalTrials.gov with ChromX Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploration and Study on the Identification of Various Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
- Lead sponsor
- ChromX Health
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 30, 2024
- Completion date
- June 30, 2027
- Enrollment
- 10,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bronchial asthma, bronchiectasis, bronchitis, copd, cystic fibrosis of the lung, emphysema, interstitial lung disease, lung cancer, lung infection, lung injury, preserved ratio impaired spirometry, pulmonary abscess, pulmonary arterial hypertension, pulmonary embolism, pulmonary fibrosis, pulmonary tuberculosis